Zacks Investment Research upgraded shares of STAR SCIENTIFIC (STSI) from NEUTRAL to OUTPERFORM on January 02, 2013, with a target price of $3.40.
Star Scientific, Inc.'s primary focus is the research and development of products that deliver less toxins. The Company's overall objective is to reduce the range of serious health hazards associated with the use of smoked tobacco products. Accordingly, its primary corporate mission is to demonstrate the commercial viability of products that deliver less toxins and are potentially less harmful.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on STAR SCIENTIFIC (STSI),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment